Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Oct 31;12:8977–8989. doi: 10.2147/OTT.S218182

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Lv et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Effects of Bag-1 siRNA and cisplatin on the regulation of cell cycle redistribution. (A) A549 cells were grown and infected by Bag-1 or negative control siRNA for 48 hrs and then treated with 5 μg/mL cisplatin for 24 hrs and subjected to a flow cytometric cell cycle assay. (B) The columns indicate the percentages of A549 cells at different phases. G0/G1 phase, *p=0.02 vs the non-treatment group and ^#p=0.04 vs the negative control siRNA group. The S phase, *p=0.009 vs the non-treatment group and ^#p=0.002 vs the negative control siRNA group.